|
|
 |
|
Literature : Books, Journals, Literature
|
|
| Reviews 2007 |
| 1. |
Moens, A. L. and D. A. Kass (2007). "Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease." J Cardiovasc Pharmacol 50(3): 238-46.
|
|
| 2. |
Scriver, C. R. (2007). "The PAH gene, phenylketonuria, and a paradigm shift." Hum Mutat. 28(9),831-845,
|
|
| Reviews 2006 |
| 3. |
Blau, N. (2006). "Differentialdiagnose der Hyperphenylalaninämien: Screening auf angeborene Stoffwechselkrankheiten." Kinder- und Jugendmedizin 4: 225-232.[Article in German]
|
|
| 4. |
Thöny, B. (2006). Tetrahydrobiopterin and its function. PKU and BH4: Advances in Phenylketonuria and Tetrahydrobiopterin Research. N. Blau. Heilbronn, SPS Publications: 503-554.
|
|
| 5. |
Thöny, B. and K. M. Gibson (2006). "Murine models of inherited monoaminergic and GABAegic neurotransmitter disorders." Future Neurol 1: 665-676.
|
|
| 6. |
Thöny, B. and N. Blau (2006). "Mutations in the BH4-metabolizing genes GTP cyclohydroalse I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase genes." Human Mutat 27: 870-878.
|
|
| Reviews 2004 |
| 7. |
Channon, K. (2004). "Tetrahydrobiopterin regulator of endothelial nitric oxide synthase in vascular disease." Trends Cardiovasc Med 14(8): 323-7.
|
|
| 8. |
Ding, Z., H. Harding and B. Thöny (2003). "State-of-the-art 2003 on PKU gene therapy." Mol Genet Metab 81: 3-8.
|
|
| Reviews 2003 |
| 9. |
Alp, N. J. and K. M. Channon (2003). "Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease." Arterioscler Thromb Vasc Biol.
|
|
| 10. |
Wei, C. C., B. R. Crane and D. J. Stuehr (2003). "Tetrahydrobiopterin radical enzymology." Chem Rev 103(6): 2365-84.
|
|
| 11. |
Werner, E. R., A. C. Gorren, R. Heller, G. Werner-Felmayer and B. Mayer (2003). "Tetrahydrobiopterin and Nitric Oxide: Mechanistic and Pharmacological Aspects." Exp Biol Med (Maywood) 228(11): 1291-1302.
|
|
| Reviews 2002 |
| 12. |
Mendel, R. R. and R. Hansch (2002). "Molybdoenzymes and molybdenum cofactor in plants." J Exp Bot 53(375): 1689-98.
|
|
| Reviews 2001 |
| 13. |
Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001;357(Pt 3):593-615.
|
|
| 14. |
Blau N, Bonafé L, Thöny B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: Diagnosis and genetics of Dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 2001; 74, 172-185
|
|
| 15. |
Blau N, Thöny B, Cotton RGH, Hyland K. Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001: 1725-1776.
|
|
| Reviews 2000 |
| 16. |
Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration, and functions. Biochem J 2000:347:1-16
|
|
|
|
